Given investment horizon of 30 days, Delcath Systems Inc. is expected to under-perform the Acura. In addition to that, Delcath is 1.48 times more volatile than Acura Pharmaceuticals Inc.. It trades about -0.17 of its total potential returns per unit of risk. Acura Pharmaceuticals Inc. is currently generating about -0.23 per unit of volatility. If you would invest 325.00 in Acura Pharmaceuticals Inc. on April 25, 2012 and sell it today you would lose (48.00) from holding Acura Pharmaceuticals Inc. or give up 14.77% of portfolio value over 30 days.
Diversification
Average diversification
Overlapping area represents amount of risk that can be diversified away by holding Delcath Systems Inc. and Acura Pharmaceuticals Inc. in the same portfolio (assuming nothing else is changed)
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
